Acute pancreatitis as a risk factor of chronic pancreatitis and pancreatic cancer. An overview.
1/5 보강
This is an overview of relation between acute and chronic pancreatitis and between acute pancreatitis and pancreatic cancer.
APA
Solil D, Dite P, et al. (2024). Acute pancreatitis as a risk factor of chronic pancreatitis and pancreatic cancer. An overview.. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 168(4), 284-287. https://doi.org/10.5507/bp.2024.023
MLA
Solil D, et al.. "Acute pancreatitis as a risk factor of chronic pancreatitis and pancreatic cancer. An overview.." Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, vol. 168, no. 4, 2024, pp. 284-287.
PMID
39254152 ↗
Abstract 한글 요약
This is an overview of relation between acute and chronic pancreatitis and between acute pancreatitis and pancreatic cancer. Acute pancreatitis and recurrent acute pancreatitis are an etiological factor of chronic pancreatitis. Population-based studies have calculated the risk of acute recurrent pancreatitis after the first attack of acute pancreatitis to be 20% and development of chronic pancreatitis after first attack of acute pancreatitis is 10%. An important risk factor is tobacco smoking. Acute and chronic pancreatitis are risk factors for pancreatic cancer. The risk of acute pancreatitis is related to the number of recurrences of acute pancreatitis, but not the etiology of acute pancreatitis. Acute pancreatitis, as well as chronic pancreatitis, are risk factors for pancreatic cancer. After an attack of acute pancreatitis or recurrent acute pancreatitis a patient should be regarded as a high risk.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.